First chewable oral contraceptive
Fda Consumer 38(2): 4
2004
ISSN/ISBN: 0362-1332
PMID: 15101351
Accession: 049085968
PDF emailed within 1 workday: $29.90
Related References
Boissonneault, R.M.; Devries, T.M. 2003: Chewable oral contraceptive Official Gazette of the United States Patent and Trademark Office Patents 1277(4)Weisberg, E. 2012: A chewable low-dose oral contraceptive: a new birth control option? Patient Preference and Adherence 6: 355-360
Audet, M.C.; Moreau, M.; Koltun, W.D.; Waldbaum, A.S.; Shangold, G.; Fisher, A.C.; Creasy, G.W. 2001: Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial JAMA 285(18): 2347-2354
Bagdade, J.D.; Subbaiah, P.V. 1982: Atherosclerosis and oral contraceptive use. Serum from oral contraceptive users stimulates growth of arterial smooth muscle cells Arteriosclerosis 2(2): 170-176
Rushton, L.; Jones, D.R. 1992: Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use British Journal of Obstetrics and Gynaecology 99(3): 239-246
Fraser, I.S.; Jansen, R.P. 1983: Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors Contraception 27(6): 531-551
Kaul, L.; Ahluwalia, B. 1978: Interrelation of caffeine and oral contraceptive steroid metabolism in hypertensive oral contraceptive users in humans Journal of Steroid Biochemistry 9(9): 862-863
Hampton, R.M.; Short, M.; Bieber, E.; Bouchard, C.; Ayotte, N.; Shangold, G.; Fisher, A.C.; Creasy, G.W. 2001: Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20 Contraception 63(6): 289-295
Hannaford, P.C.; Kay, C.R. 1998: The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study British Journal of General Practice: the Journal of the Royal College of General Practitioners 48(435): 1657-1662
de Vries, C.S.; van den Berg, P.B.; de Jong-van den Berg, L.T. 1998: Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change Contraception 57(4): 247-249
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Subbaiah, P.V.; Bagdade, J.D. 1980: Oral contraceptive steroids and atherosclerosis: lipogenesis in human arterial smooth muscle cells and dermal fibroblasts in presence of lipoprotein-deficient serum from oral contraceptive users Artery 6(6): 437-457
Hall, K.S.; Castaño, P.M.; Westhoff, C.L. 2014: The influence of oral contraceptive knowledge on oral contraceptive continuation among young women Journal of Women's Health 23(7): 596-601
Samy Suissa; Brenda Hemmelgarn; Walter, O. Spitzer; James Brophy; Jean-Paul Collet; Robert Cǒte; Winanne Downey; Lindsay Edouard; Jacques Leclerc; Ora Paltiel 1993: The Saskatchewan oral contraceptive cohort study of oral contraceptive use and cardiovascular risks Pharmacoepidemiology and Drug Safety 2(1): 33-49
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144